SPRO
Spero Therapeutics, Inc. (SPRO) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
SPRO’s disclosed R&D intensity is high versus many software peers, which can support product efficiency, but it does not by itself indicate superior environmental management.
The company’s capital-light balance sheet and low debt reduce financing pressure for environmental remediation, yet peers with explicit climate disclosures still appear better positioned.
No Tier 1 evidence provided here indicates material emissions, energy, or waste advantages, so SPRO’s environmental profile remains largely disclosure-limited versus peers.
Because environmental risk appears more about limited transparency than structural exposure, SPRO sits near the peer middle rather than among leaders.
Social
SPRO’s elevated R&D spend relative to revenue suggests sustained investment in product development, which can support workforce skill retention versus less innovative peers.
Stock-based compensation at 7.4% of revenue indicates meaningful employee alignment, but peers with lower dilution and stronger retention programs may be better positioned.
No provided filing evidence shows material labor, customer-safety, or community controversies, which avoids a clear social disadvantage versus peers.
However, the absence of disclosed social metrics limits confidence, leaving SPRO’s social positioning broadly adequate but not clearly differentiated.
Governance
Low debt-to-equity and negative net debt to EBITDA indicate conservative capital structure, which reduces governance pressure from creditor constraints versus leveraged peers.
Stock-based compensation at 7.4% of revenue is manageable but still meaningful, so governance quality depends on whether dilution is tightly controlled relative to peers.
The provided metrics do not show severe governance red flags, but they also do not evidence the stronger disclosure and oversight practices seen at top-tier peers.
Overall governance appears stable and non-problematic, yet SPRO lacks the clear structural advantages needed to rank above stronger-disclosing peers.
Overall Score
SPRO’s ESG positioning is broadly middle-of-the-pack versus peers, with conservative capital structure offset by limited disclosure and no clear evidence of leading ESG practices.
Score Driver: The Decisive Factor Is Disclosure-Limited ESG Visibility, Which Prevents SPRO From Demonstrating A Structural Advantage Over Better-Disclosed Peers.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Spero Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
